Parallax Volatility Advisers
FATE icon

Parallax Volatility Advisers’s Fate Therapeutics FATE Stock Holding History

Parallax Volatility Advisers’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-199
Closed -$18K – 1310
2020
Q4 		$18K Buy
+199
New +$12.4K ﹤0.01% 2108
2020
Q2 		– Sell
-11,726
Closed -$260K – 2760
2020
Q1 		$260K Buy
11,726
+1,122
+11% +$28.4K ﹤0.01% 1923
2019
Q4 		$208K Buy
+10,604
New +$168K ﹤0.01% 1998
2019
Q2 		– Sell
-5,000
Closed -$88K – 2895
2019
Q1 		$88K Buy
+5,000
New +$78.9K ﹤0.01% 2148
2018
Q1 		– Sell
-5,796
Closed -$35K – 2838
2017
Q4 		$35K Buy
+5,796
New +$25.9K ﹤0.01% 3403

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return